Judah Frommer

Kyuwon Choi

Sean McCutcheon

Yi Chen

Alec Stranahan

Annabel Samimy

Brian Skorney

Daniil Gataulin

Jack Padovano

Lisa Walter

Mani Foroohar

Ryan Mcelroy

Bill Maughan

Eliana Merle

Ellie Merle

Gena Huidong Wang

Gospel Enyindah-Asonye

Huidong Wang

Luca Issi

Luke Lapointe

Paul Choi

Qian Wang

Shelby Tucker

Tejas Vyas

- **REGENXBIO** will present new analysis of 12-month functional data from the Phase I/II trial of **RGX-202** at the International Congress of the World Muscle Society on **October 8, 2025**.  **[1590877_20250929PH85182:0]** 
- The presentation will detail results for **RGX-202**, an investigational gene therapy for **Duchenne muscular dystrophy**, which demonstrated a **favorable safety profile** with no serious adverse events.  **[1590877_20250929PH85182:0]** 
- Pivotal dose participants in the trial **exceeded baseline-matched external natural history controls** on all functional measures, suggesting **RGX-202's** potential as a **differentiated, best-in-class gene therapy**.  **[1590877_20250929PH85182:0]**

REGENXBIO Announces Presentation of RGX-202 Clinical Data

REGENXBIO (RGNX)